Acurx Pharmaceuticals Inc (ACXP)
2.07
+0.05
(+2.48%)
USD |
NASDAQ |
Apr 26, 16:00
2.10
+0.03
(+1.45%)
After-Hours: 20:00
Acurx Pharmaceuticals Total Assets (Quarterly): 7.709M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.709M |
| September 30, 2023 | 7.158M |
| June 30, 2023 | 9.236M |
| March 31, 2023 | 7.385M |
| December 31, 2022 | 9.377M |
| September 30, 2022 | 10.95M |
| June 30, 2022 | 9.259M |
| Date | Value |
|---|---|
| March 31, 2022 | 11.32M |
| December 31, 2021 | 13.25M |
| September 30, 2021 | 14.99M |
| June 30, 2021 | 17.44M |
| March 31, 2021 | 2.982M |
| December 31, 2020 | 3.224M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.982M
Minimum
Mar 2021
17.44M
Maximum
Jun 2021
9.560M
Average
9.259M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp | 154.46M |
| Seelos Therapeutics Inc | 5.418M |
| PetVivo Holdings Inc | 3.630M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.042M |
| Shareholders Equity (Quarterly) | 57.89M |